Outpatient Total Joint Arthroplasty

Outpatient Lower Extremity Total Joint Arthroplasty: Where Are We Heading?

By the end of 2050, the incidences of hip and knee arthroplasties performed in the United States are projected to be more than 1.8 million and 4 million, respectively.1 In 2014 alone, more than 1 million elective lower extremity arthroplasties were performed, with collective per procedure expenditures ranging from $16,500 to $75,000. This disbursement covered surgery, hospitalization, and rehab...

Tranexamic Acid in Total Joint Arthroplasty: Efficacy and Safety

  Despite improvements in surgical and anesthetic techniques, total joint arthroplasty (TJA) is still associated with substantial blood loss and postoperative anemia (1). A considerable portion of patients with postoperative anemia require blood transfusion, which has been shown to negatively affect the outcome of TJA and predisposes patients to development of surgical site infection and peripr...

Malnutrition and Total Joint Arthroplasty.

Malnutrition is prevalent in patients undergoing elective total joint arthroplasty (TJA). Malnutrition has been shown to be an independent risk factor for multiple postsurgical complications following TJA in addition to increasing postoperative mortality. In the current healthcare environment, it is important to recognize and correct modifiable risk factors preoperatively to minimize perioperat...

Total Joint Arthroplasty for Hemophilia

Hemophilia is hereditary x-chromosomal recessive disorders. Hemophilia A is caused by deficiency or absence of coagulation factor VIII and hemophilia B is caused by that of coagu‐ lation factor IX. The prevalence is reported as one in 5000 in the male population and one in 10000 overall. These diseases are classified into three categories according to serum coagula‐ tion factor activity; severe...

Obesity and Total Joint Arthroplasty